Search all trials

Find therapies in clinical trials near you – page 26

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Thrombotic microangiopathy

Not recruiting

Registered drug

Study on Ravulizumab for Patients with Thrombotic Microangiopathy After Stem Cell Transplant

Registered drug

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Ravulizumab

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study of JNJ-68284528 for Treating Multiple Myeloma in Patients Using Ciltacabtagene Autoleucel and Drug Combination

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

B-cell lymphoma

Not recruiting

InvestigationalNo placebo

Long-term Study of Zanubrutinib for Patients with B-cell Blood Cancer

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Zanubrutinib

Contact Research Centre

Non-small cell lung cancer stage IV

Not recruiting

Registered drugNo placebo

Study on Brigatinib for Patients with ALK+ Non-Small Cell Lung Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Brigatinib

Contact Research Centre

Prodromal Alzheimer's disease

Not recruiting

Registered drug

Study of RO7269162 in people at risk for or with early-stage Alzheimer's Disease: Effects on brain amyloid buildup

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Florbetaben (18F)

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

InvestigationalNo placebo

Long-Term Safety Study of Inhaled Imatinib for Patients with Pulmonary Arterial Hypertension

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Imatinib

Contact Research Centre

HER2 positive breast cancer

Not recruiting

Registered drug

Study on Atezolizumab and Trastuzumab Emtansine for Patients with HER2-Positive Breast Cancer at High Risk of Recurrence After Preoperative Therapy

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Breast cancer

Not recruiting

Registered drug

Study on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Olaparib

Contact Research Centre

Myelofibrosis

Not recruiting

Registered drugNo placebo

Study of Imetelstat Compared to Drug Combination for Treating Intermediate-2 or High-Risk Myelofibrosis in Patients Not Responding to JAK-Inhibitor Treatment

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:ALKYLATING AGENTS

Contact Research Centre

Plasma cell myeloma+1

Not recruiting

Registered drugNo placebo

Study Comparing Ciltacabtagene Autoleucel with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed and Lenalidomide-Refractory Multiple Myeloma

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Non-small cell lung cancer+1

Not recruiting

Registered drugNo placebo

Study of Chemotherapy and Nivolumab Before and After Surgery for Patients with Non-Small Cell Lung Cancer in the Upper Lung Area

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Essential thrombocythaemia

Not recruiting

Registered drugNo placebo

Study on Bomedemstat for Patients with Essential Thrombocythemia Not Responding to or Intolerant of Hydroxyurea, Comparing with a Drug Combination

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Bomedemstat

Contact Research Centre

Find therapies in clinical trials near you – page 26

441 trials match your criteria

Thrombotic microangiopathy

Study on Ravulizumab for Patients with Thrombotic Microangiopathy After Stem Cell Transplant

Plasma cell myeloma

Study of JNJ-68284528 for Treating Multiple Myeloma in Patients Using Ciltacabtagene Autoleucel and Drug Combination

B-cell lymphoma

Long-term Study of Zanubrutinib for Patients with B-cell Blood Cancer

Non-small cell lung cancer stage IV

Study on Brigatinib for Patients with ALK+ Non-Small Cell Lung Cancer

Prodromal Alzheimer's disease

Study of RO7269162 in people at risk for or with early-stage Alzheimer's Disease: Effects on brain amyloid buildup

Pulmonary arterial hypertension

Long-Term Safety Study of Inhaled Imatinib for Patients with Pulmonary Arterial Hypertension

HER2 positive breast cancer

Study on Atezolizumab and Trastuzumab Emtansine for Patients with HER2-Positive Breast Cancer at High Risk of Recurrence After Preoperative Therapy

Breast cancer

Study on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy

Myelofibrosis

Study of Imetelstat Compared to Drug Combination for Treating Intermediate-2 or High-Risk Myelofibrosis in Patients Not Responding to JAK-Inhibitor Treatment

Plasma cell myeloma+1

Study Comparing Ciltacabtagene Autoleucel with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed and Lenalidomide-Refractory Multiple Myeloma

Non-small cell lung cancer+1

Study of Chemotherapy and Nivolumab Before and After Surgery for Patients with Non-Small Cell Lung Cancer in the Upper Lung Area

Essential thrombocythaemia

Study on Bomedemstat for Patients with Essential Thrombocythemia Not Responding to or Intolerant of Hydroxyurea, Comparing with a Drug Combination

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.